HCR Update from Mark Sanna: On Thursday, the U.S. House of Representatives, largely along party lines, passed  H.R. 5, a bill designed to abolish an independent board responsible for curbing Medicare spending growth and restricting medical-malpractice lawsuits. An amendment was added on the House floor that would end the current exemption from antitrust laws that health insurance companies currently enjoy.